This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by LEO Pharma.
Reference
Tolley K, et al. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective. European Journal of Health Economics : 21 Mar 2015. Available from: URL: http://dx.doi.org/10.1007/s10198-015-0679-8
Rights and permissions
About this article
Cite this article
Ingenol mebutate gel cost effective for AK treatment in Scotland. PharmacoEcon Outcomes News 725, 16 (2015). https://doi.org/10.1007/s40274-015-2030-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2030-0